Maija-Leena HOLLMÉN

Person

Piispanristi, FI

People

Patents Grantslast 30 patents

Information Patent Grant
Method of monitoring the efficacy of the anti-clever-1 therapy in c...
- Patent number 10,884,000
- Issue date Jan 5, 2021
- Faron Pharmaceuticals Oy
- Maija-Leena Hollmén
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CLEVER-1 AGENTS FOR CONTROLLING THE EXPRESSION OF CELL SURFACE...
- Publication number 20220404366
- Publication date Dec 22, 2022
- Faron Pharmaceuticals Oy
- Maija-Leena HOLLMÉN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONTROLLING OF IMMUNE ACTIVATION BY SOLUBLE CLEVER-1
- Publication number 20220227858
- Publication date Jul 21, 2022
- Faron Pharmaceuticals Oy
- Juho JALKANEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TLR9 AGONISTS FOR USE IN DOWNREGULATING CLEVER-I EXPRESSION ON ALTE...
- Publication number 20210371865
- Publication date Dec 2, 2021
- Faron Pharmaceuticals Oy
- Maija-Leena HOLLMÉN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER WITH CLEVER-1 INHIBITION IN COMBINATION WITH PD...
- Publication number 20210261657
- Publication date Aug 26, 2021
- Faron Pharmaceuticals Oy
- Maija-Leena HOLLMÉN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CLEVER-1 AGENTS FOR CONTROLLING LYSOSOMAL VATPASE PROTON PUMPS...
- Publication number 20210087264
- Publication date Mar 25, 2021
- Faron Pharmaceuticals Oy
- Maija-Leena HOLLMÉN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAGNOSIS OF IMMUNE_ACTIVATION USING CLEVER-1, TNF-ALPHA AND HLA-DR...
- Publication number 20190064180
- Publication date Feb 28, 2019
- Faron Pharmaceuticals Oy
- Maija-Leena HOLLMÉN
- C07 - ORGANIC CHEMISTRY

Maija-Leena HOLLMÉN

Person

Patents Grantslast 30 patents

Method of monitoring the efficacy of the anti-clever-1 therapy in c...

Patents Applicationslast 30 patents

ANTI-CLEVER-1 AGENTS FOR CONTROLLING THE EXPRESSION OF CELL SURFACE...

CONTROLLING OF IMMUNE ACTIVATION BY SOLUBLE CLEVER-1

TLR9 AGONISTS FOR USE IN DOWNREGULATING CLEVER-I EXPRESSION ON ALTE...

TREATMENT OF CANCER WITH CLEVER-1 INHIBITION IN COMBINATION WITH PD...

ANTI-CLEVER-1 AGENTS FOR CONTROLLING LYSOSOMAL VATPASE PROTON PUMPS...

DIAGNOSIS OF IMMUNE_ACTIVATION USING CLEVER-1, TNF-ALPHA AND HLA-DR...